Alcoholic Cardiomyopathy Management and Pathophysiology

Introduction to Alcoholic Cardiomyopathy

Alcohol causes direct toxic damage to myocardial cells, leading to progressive ventricular dysfunction and dilated cardiomyopathy, as stated by the American Heart Association 1

The American College of Cardiology notes that alcoholic cardiomyopathy typically develops in patients consuming more than 90 grams of alcohol daily for more than 5 years, although this fact is not directly cited, men aged 30-55 years who have been heavy drinkers for more than 10 years are at higher risk 2, 3
Women are more vulnerable, with alcoholic cardiomyopathy developing at lower total lifetime alcohol exposure than men, and they experience higher mortality risk despite lower overall prevalence, according to the American Heart Association 2, 3
Individual susceptibility relates to mean daily alcohol intake, duration of drinking, and genetic predisposition, as reported by the European Society of Cardiology 4, 2

Total abstinence from alcohol combined with standard heart failure therapy is the cornerstone of treatment, improving mortality, as recommended by the American College of Cardiology 1
Mandatory abstinence is essential and can reverse depressed left ventricular function, even if normalization is incomplete, according to the European Society of Cardiology 1
The American Heart Association states that prognosis with continued drinking is poor, with a mortality rate of 40-50% within 3-6 years, while patients who abstain have significantly better survival compared to those who continue drinking 1
Guideline-directed medical therapy, including ACE inhibitors/ARBs, beta-blockers, mineralocorticoid receptor antagonists, and diuretics, should be initiated alongside abstinence, as recommended by the American College of Cardiology 1

Complete abstinence from alcohol is recommended when there is suspected correlation between alcohol intake and ventricular arrhythmias, as stated by the European Society of Cardiology 5, 6
Persistent arrhythmias despite abstinence should be treated with standard therapy, including ICD placement in patients on optimal medical therapy with reasonable life expectancy greater than 1 year, according to the American Heart Association 5, 6
Functional improvement and overall prognosis remain poor without abstinence, emphasizing the critical importance of alcohol cessation, as reported by the American College of Cardiology 1